Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli
about
Filamentation by Escherichia coli subverts innate defenses during urinary tract infectionThe arsenal of pathogens and antivirulence therapeutic strategies for disarming themIntracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract SymptomsEarly severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infectionUrinary Tract Infection: Pathogenesis and Outlook.Dynamics of intracellular bacterial replication at the single cell level.Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.Detection of intracellular bacterial communities in human urinary tract infection.Waging war against uropathogenic Escherichia coli: winning back the urinary tractCharacterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence.Persistence of uropathogenic Escherichia coli in the face of multiple antibioticsCellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccineSyntheses and biological evaluation of 2-amino-3-acyl-tetrahydrobenzothiophene derivatives; antibacterial agents with antivirulence activityIntrauterine growth restriction is a direct consequence of localized maternal uropathogenic Escherichia coli cystitisA murine model of urinary tract infection.The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilitiesBacterial differentiation, development, and disease: mechanisms for survival.Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in womenUropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection.Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tractForced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirsAre you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.Complete Genome Sequence of Uropathogenic Escherichia coli Strain CI5Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunityInhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis.Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation.Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder CellsThe interplay of extracellular matrix and microbiome in urothelial bladder cancer.Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model.Covert operations of uropathogenic Escherichia coli within the urinary tract.Carbon monoxide releasing molecule-2 (CORM-2) inhibits growth of multidrug-resistant uropathogenic Escherichia coli in biofilm and following host cell colonization.Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosidesCombinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.New paradigms of urinary tract infections: Implications for patient management.A Murine Model for Escherichia coli Urinary Tract Infection.Viable but nonculturable bacteria are present in mouse and human urine specimens.Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children.Molecular detection of antimicrobial resistance in local isolates of Staphylococcus epidermidis from urinary tract infections in Faisalabad region of Pakistan
P2860
Q24676540-05196C63-6EA8-4AF5-A7DA-A55D9BF89008Q26745604-1895F729-B89E-4B4E-85E0-67DB7A0A81F0Q26799248-EAFA056F-C91C-45C2-B444-C6D2EEDEE6D0Q28475353-BB420421-BEAE-4ED3-BF16-7EB7399BDC75Q30244953-A74A85FC-32AE-4A27-B848-5B5154CC3FB4Q30493738-C445958C-7EDC-4968-AC97-FEAC74FBDCB4Q30515509-245842D9-084C-47F9-B84D-8CB1C3A184C0Q33290835-812778A9-53FF-4AAC-8413-85C73A99C540Q33311340-3B3CFB04-73EE-4DE8-A2F4-8CA329129B36Q33613902-CCDA0B84-E42D-470C-91E6-8EBF4662781CQ33826150-FFDA3AD1-6E04-4683-AE22-CE8C90246BE2Q33826366-48BEBDD5-966C-494E-AF4F-85D791D10D49Q33850497-C597572D-0880-40E5-A476-160E9012FCC4Q34118181-80E5209C-E243-47E7-BFE9-642072723BA3Q34217562-2CD47D40-F4A6-4651-A69E-5E58216C5D3EQ34236010-02A0FCEF-0D68-475D-BE74-6BCCEA0FE953Q34431394-F0F19429-9B00-4C67-B768-A72DD02EEA76Q34490425-88E63762-6676-46FC-97CA-4E3165B2DF09Q34680794-1B077E16-7CF6-4549-8D73-22B9987C3849Q34876396-67A7534B-B9DA-48EA-ABF9-D5278749F69FQ35024747-E2D105DE-0B27-4D32-A1DF-B52F973E75E1Q35131385-42BDC7B1-C374-4DA7-907E-ED2E59917B3AQ35195313-894DE489-452E-4B17-A238-678FE4B77501Q35197365-59957339-9F65-4EE0-8AC9-4C8C7AAEEA3DQ35662142-E95A9924-1345-4A84-BC9C-484D6385FA33Q35677483-4FF0B880-EF12-485D-9F96-B57713B51F9EQ35687994-3D30D3E1-09AD-4BA6-BB51-0010E00E07ADQ35688937-982B1DEC-1DC1-435E-878D-79E025D6EF25Q35738930-0BCA9C14-598A-4F42-ACD5-439D1B09D901Q35868405-8E9C03BE-3ADF-4FEE-8E29-E16B918221A6Q35960915-AA4DF262-7F04-4105-BB4C-DAC59EF29B92Q35966152-A487178E-478C-450D-BF76-70C20080F318Q35986311-F6588DDB-278F-4B21-B3FE-408693C66D99Q36032748-FA406713-6AB6-4DB2-9887-9B30F1C223D4Q36172411-4A5D1C55-B492-4FC7-A16D-7A9E2134A5D1Q36181046-1A250DCE-BB24-4C17-AE1B-99612F777A9AQ36219597-191197DC-ABA3-4759-BED3-6AED6FCF887DQ36241100-C20FF7E9-517E-4CB0-80F4-35ED9C991233Q36293989-3E77D93A-EDC4-4D0B-9CB1-B2FCF9BC6121Q36347550-8D6CC072-5C98-4F99-AA8C-FA73A7787565
P2860
Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effect of trimethoprim-sulfame ...... uropathogenic Escherichia coli
@ast
Effect of trimethoprim-sulfame ...... uropathogenic Escherichia coli
@en
Effect of trimethoprim-sulfame ...... uropathogenic Escherichia coli
@nl
type
label
Effect of trimethoprim-sulfame ...... uropathogenic Escherichia coli
@ast
Effect of trimethoprim-sulfame ...... uropathogenic Escherichia coli
@en
Effect of trimethoprim-sulfame ...... uropathogenic Escherichia coli
@nl
prefLabel
Effect of trimethoprim-sulfame ...... uropathogenic Escherichia coli
@ast
Effect of trimethoprim-sulfame ...... uropathogenic Escherichia coli
@en
Effect of trimethoprim-sulfame ...... uropathogenic Escherichia coli
@nl
P2860
P1476
Effect of trimethoprim-sulfame ...... uropathogenic Escherichia coli
@en
P2093
Joel D Schilling
P2860
P304
P356
10.1128/IAI.70.12.7042-7049.2002
P407
P577
2002-12-01T00:00:00Z